Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterisation of Relative Bioavailability and Assessment of Bioequivalence of a Newly Developed Ethinylestradiol/Dienogest IR Formulation in Comparison With a Marketed Reference Product (Valette®)

NCT01600274 is registered in ClinicalTrials.gov with Pharbil Waltrop GmbH as lead sponsor.

NCT NCT01600274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01600274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterisation of Relative Bioavailability and Assessment of Bioequivalence of a Newly Developed Ethinylestradiol/Dienogest IR Formulation in Comparison With a Marketed Reference Product (Valette®)
Lead sponsor
Pharbil Waltrop GmbH
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2010
Completion date
February 28, 2010
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

focus: bioequivalence